BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 16299229)

  • 1. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.
    Willipinski-Stapelfeldt B; Riethdorf S; Assmann V; Woelfle U; Rau T; Sauter G; Heukeshoven J; Pantel K
    Clin Cancer Res; 2005 Nov; 11(22):8006-14. PubMed ID: 16299229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
    J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases.
    Putz E; Witter K; Offner S; Stosiek P; Zippelius A; Johnson J; Zahn R; Riethmüller G; Pantel K
    Cancer Res; 1999 Jan; 59(1):241-8. PubMed ID: 9892213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
    Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
    J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vimentin and epithelial-mesenchymal transition in human breast cancer--observations in vitro and in vivo.
    Kokkinos MI; Wafai R; Wong MK; Newgreen DF; Thompson EW; Waltham M
    Cells Tissues Organs; 2007; 185(1-3):191-203. PubMed ID: 17587825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of epithelial-mesenchymal transition in breast cancer.
    Fuchs IB; Lichtenegger W; Buehler H; Henrich W; Stein H; Kleine-Tebbe A; Schaller G
    Anticancer Res; 2002; 22(6A):3415-9. PubMed ID: 12530097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors.
    Zhang DH; Tai LK; Wong LL; Sethi SK; Koay ES
    Proteomics; 2005 May; 5(7):1797-805. PubMed ID: 15825149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines.
    Sommers CL; Heckford SE; Skerker JM; Worland P; Torri JA; Thompson EW; Byers SW; Gelmann EP
    Cancer Res; 1992 Oct; 52(19):5190-7. PubMed ID: 1382837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells.
    Reimers N; Zafrakas K; Assmann V; Egen C; Riethdorf L; Riethdorf S; Berger J; Ebel S; Jänicke F; Sauter G; Pantel K
    Clin Cancer Res; 2004 May; 10(10):3422-8. PubMed ID: 15161697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of metastasis-related proteins and their clinical relevance to triple-negative human breast cancer.
    Sun B; Zhang S; Zhang D; Li Y; Zhao X; Luo Y; Guo Y
    Clin Cancer Res; 2008 Nov; 14(21):7050-9. PubMed ID: 18981002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.
    Soltermann A; Tischler V; Arbogast S; Braun J; Probst-Hensch N; Weder W; Moch H; Kristiansen G
    Clin Cancer Res; 2008 Nov; 14(22):7430-7. PubMed ID: 19010860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential protein profiling of primary versus immortalized human RPE cells identifies expression patterns associated with cytoskeletal remodeling and cell survival.
    Alge CS; Hauck SM; Priglinger SG; Kampik A; Ueffing M
    J Proteome Res; 2006 Apr; 5(4):862-78. PubMed ID: 16602694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of differential protein expression in normal and neoplastic human breast epithelial cell lines.
    Williams K; Chubb C; Huberman E; Giometti CS
    Electrophoresis; 1998 Feb; 19(2):333-43. PubMed ID: 9548300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium.
    Hudelist G; Singer CF; Pischinger KI; Kaserer K; Manavi M; Kubista E; Czerwenka KF
    Proteomics; 2006 Mar; 6(6):1989-2002. PubMed ID: 16470630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease.
    Kluger HM; Chelouche Lev D; Kluger Y; McCarthy MM; Kiriakova G; Camp RL; Rimm DL; Price JE
    Cancer Res; 2005 Jul; 65(13):5578-87. PubMed ID: 15994930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
    Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
    J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLC-beta2 is highly expressed in breast cancer and is associated with a poor outcome: a study on tissue microarrays.
    Bertagnolo V; Benedusi M; Querzoli P; Pedriali M; Magri E; Brugnoli F; Capitani S
    Int J Oncol; 2006 Apr; 28(4):863-72. PubMed ID: 16525635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High HSP90 expression is associated with decreased survival in breast cancer.
    Pick E; Kluger Y; Giltnane JM; Moeder C; Camp RL; Rimm DL; Kluger HM
    Cancer Res; 2007 Apr; 67(7):2932-7. PubMed ID: 17409397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein profile changes in the human breast cancer cell line MCF-7 in response to SEL1L gene induction.
    Bianchi L; Canton C; Bini L; Orlandi R; Ménard S; Armini A; Cattaneo M; Pallini V; Bernardi LR; Biunno I
    Proteomics; 2005 Jun; 5(9):2433-42. PubMed ID: 15880780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.